ClinicalTrials.Veeva

Menu
M

MedPharmics, LLC | Metairie, LA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rimegepant
MK-4482
GLPG1972
Dextromethorphan
CAMB
fezolinetant
RHB-105
TJ003234
Amphotericin B
MHAA4549A

Parent organization

This site is a part of MedPharmics, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 46 total trials

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...

Enrolling
SARS-CoV-2
Biological: mRNA-1273.815
Biological: mRNA-1273.214

This study evaluates an investigational vaccine that is designed to protect humans against infection with respiratory syncytial virus (RSV) and is ad...

Enrolling
Respiratory Syncytial Virus (RSV)
Biological: Investigational RSV vaccine MV-012-968 (Dosage 3; single-dose)
Other: Placebo (two-dose)

To evaluate the safety and effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities compared to Conventional Medical Management (CMM)...

Active, not recruiting
Chronic Pain
Other: Conventional Medical Managament
Device: WaveWriter

The primary objective of the study is to demonstrate the non-inferiority of the antibody response in terms of seroconversion rate 28 days after vacci...

Active, not recruiting
Yellow Fever (Healthy Volunteers)
Biological: Yellow fever vaccine (produced on serum-free Vero cells)
Biological: Yellow fever vaccine

Trial sponsors

Pfizer logo
Moderna logo
Merck Sharp & Dohme (MSD) logo
Genentech logo
Janssen (J&J Innovative Medicine) logo
Sanofi logo
A
Abbott logo
Abbott logo
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems